Impax Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $19.9M | Sell |
154,303
-125,453
| -45% | -$16.2M | 1.18% | 19 |
|
|
2018
Q1 | $28.8M | Sell |
279,756
-1,603
| -0.6% | -$165K | 1.66% | 6 |
|
|
2017
Q4 | $24M | Sell |
281,359
-11,092
| -4% | -$947K | 1.38% | 14 |
|
|
2017
Q3 | $24.8M | Hold |
292,451
| – | – | 1.42% | 13 |
|
|
2017
Q2 | $22.1M | Buy |
292,451
+16,573
| +6% | +$1.26M | 1.25% | 24 |
|
|
2017
Q1 | $18.2M | Buy |
275,878
+46,570
| +20% | +$3.07M | 1.02% | 35 |
|
|
2016
Q4 | $14.5M | Buy |
229,308
+27,251
| +13% | +$1.73M | 0.83% | 57 |
|
|
2016
Q3 | $12.9M | Buy |
202,057
+121,907
| +152% | +$7.76M | 0.74% | 63 |
|
|
2016
Q2 | $5.96M | Buy |
80,150
+24,382
| +44% | +$1.81M | 0.35% | 97 |
|
|
2016
Q1 | $3.73M | Buy |
+55,768
| New | +$3.73M | 0.2% | 115 |
|
|
2014
Q3 | – | Sell |
-74,102
| Closed | -$2.88M | – | 193 |
|
|
2014
Q2 | $2.88M | Buy |
+74,102
| New | +$2.88M | 0.18% | 101 |
|